Alimera Sciences (ALIM) Reports Q2 Loss, Tops Revenue Estimates
ALIMAlimera Sciences(ALIM) ZACKS·2024-08-06 21:40

Alimera Sciences (ALIM) came out with a quarterly loss of 0.06pershareversustheZacksConsensusEstimateofalossof0.06 per share versus the Zacks Consensus Estimate of a loss of 0.03. This compares to loss of 0.44pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof−1000.44 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -100%. A quarter ago, it was expected that this eye drug developer would post a loss of 0.04 per share when it actually produced a loss of $0.12, delivering a surprise of -200%.Over the last four quarters, the company ha ...